Immunotherapy for Allergic Rhinitis (Hay Fever)

What is Allergic Rhinitis (Hay Fever)?

sneezing manAllergic rhinitis (commonly known as hay fever) is one of the most common allergic conditions, affecting 1 in 5 adults, one in 10 teenagers and an estimated one in 20 young children. Symptoms are triggered by an immune response to otherwise harmless triggers such as pollen, house dust mite, mould or animal dander.

Signs and symptoms of hay fever may include a runny/itchy/blocked nose, lots of sneezing and watery/itchy eyes. One in five people with hay fever can also get symptoms of asthma with wheezing and shortness of breath. Those allergic to ryegrass are more prone to thunderstorm asthma, where sudden/severe attacks of asthma occur in spring and summer when grass pollen levels are high and storms occur nearby.

Hay fever is considered severe if your hay fever symptoms lead to you having one or more of the following:

  • Disturbed sleep leading to daytime drowsiness
  • Frequent waking due to breathing symptoms
  • Restricted daily activities, sport or leisure
  • Abnormal work and school performance

If symptoms are ongoing or difficult to control, even when taking medication, your doctor may refer you to a clinical immunology/allergy specialist for management. You can also request a referral. Your specialist will review your symptoms and treatment and may discuss long term treatment known as allergen immunotherapy.

Webinar with Professor Connie Katelaris shares information on allergic rhinitis

Allergic Rhinitis and Allergen Immunotherapy Webinar

View the webinar in full or go directly to information concerning allergic rhinitis by selecting the relevant titles

Brochure

Is your Allergic Rhinitis Hay Fever difficult to manage

Go to the brochure Is your Allergic Rhinitis (Hay Fever) difficult to manage? Have you heard of immunotherapy?

What is Allergen Immunotherapy (AIT)?

Allergen Immunotherapy (AIT) has been used for over 100 years and is a proven treatment providing long-term relief for hay fever. The aim of AIT is to help people react less to their trigger allergen/s that cause symptoms (such as grass pollen/house dust mite). This means having no/less symptoms and a better quality of life.

Webinar with Professor Connie Katelaris shares information on allergen immunotherapy

View the webinar in full or go directly to information concerning allergen immunotherapy by selecting the relevant titles

Who can benefit from AIT?

AIT can benefit many people including;

  • Those who have severe symptoms that are not being controlled by over the counter and prescribed medications
  • Those who wish to reduce the need for long term antihistamines and nasal sprays.
  • those who find it difficult to avoid the allergen they are allergic to (such as dust mites and grass pollens)
  • Those who do not wish to avoid the trigger, such as those working with animals or who want a pet but are allergic to them.

Those wanting to know more about AIT should speak with their doctor. For detailed advice and potential treatment, ask for a referral to a medical specialist with experience in allergy and AIT. In those with severe asthma, the option of immunotherapy needs to be carefully assessed with medical specialist advice. A medical specialist may carefully progress AIT in people with asthma as it may improve asthma control.

Treatment in women who are pregnant or planning a pregnancy should not be started, although it can be continued if a woman is on AIT and then becomes pregnant. AIT can be continued when breastfeeding.

AIT treatment is not common in children under five years of age, as often, they are not cooperative.

How is AIT delivered?

AIT can be given using different methods including by injection (sub-cutaneous immunotherapy or SCIT) or by spray, tablet or drop taken under the tongue before being swallowed (sub-lingual immunotherapy or SLIT).

Subcutaneous (injection) Therapy (SCIT)

  • AIT injected just under the skin will usually be given via a small needle, starting with a very low dose and increasing gradually until a dose decided by your medical specialist (maintenance dose) is reached.
  • Once a maintenance dose is reached, the injections will usually be given monthly, but this may vary depending on the doctor and the person. The injections are continued for 3-5 years
  • Some people may experience some redness, itching or swelling at the site of the injection. This can be managed with a non-sedating antihistamine, ice-packs and paracetamol if it is painful.
  • A more serious allergic reaction such as anaphylaxis is very uncommon, but possible. The treating doctor will have the person stay in their clinic for about 30 minutes after the injection is given so they can be watched/observed. Injections are not given at home for safety reasons.

SCIT treatments to house dust mite, grass pollens, tree pollen, mould and pets are currently available in Australia.

Oral (sublingual) Therapy (SLIT)

  • SLIT is usually taken at home, on a daily basis in the form of a tablet, spray or liquid.
  • AIT SLIT treatment usually starts at a small dose and you normally reach a daily maintenance dose within a few days.
  • Once maintenance dose is reached, treatment is continued daily for 3-5 years
  • People may experience local mild allergic reactions such as an itchy mouth or throat during the early treatment phase. These reactions usually disappear with time. They can also be managed by a non-sedating antihistamine.
  • If an individual experiences an allergic reaction that is more than a mild reaction, such as having trouble swallowing or breathing, they are to discontinue treatment immediately and contact their treating doctor. If they are concerned about serious symptoms like difficulty breathing or throat swelling, call triple zero (000) for an ambulance and seek medical attention. Severe reactions to SLIT are rare.

SLIT treatments to help manage hay fever are currently available in Australia and include treatments for grass pollens, tree pollens and house dust mite.

What is the cost of AIT?

Always speak with your doctor about the cost of AIT. A private health fund rebate may be obtained for some registered tablet and injected allergen immunotherapy products. This will depend on the level of private health insurance cover. While AIT is not cheap, ongoing medications and treatments for moderate to severe allergic rhinitis are not cheap either.

How long does AIT treatment take and how long does it last?

AIT involves regularly exposing the person to the trigger allergen that causes their allergy symptoms. Over time, repeated exposure through SCIT or SLIT ‘retrains’ the immune system to become less sensitive to the allergen. ’Retraining’ the immune system with AIT should not be seen as a ’quick fix’ but an opportunity to get better control and long-lasting relief from allergy symptoms over time. After undergoing a full course of treatment, many people are less reactive to the trigger allergen/s with less or no symptoms. People will often see an improvement in symptoms after 4-5 months of treatment. Retraining the immune system to provide long-lasting benefits takes longer. At least 3 years of treatment is needed to make sure the benefits of AIT treatment continue for several years after the person stops the treatment.

It is important that people follow the advice of their treating medical specialist and that they see their medical specialist at regular intervals during treatment. Stopping treatment too early can result in symptoms returning much sooner. If treatment does not work, there may be other reasons that need to be looked into.

For more helpful information on Immunotherapy go to www.allergy.org.au/patients/allergy-treatment/immunotherapy

Always follow the treatment plan as prescribed by your doctor. Contact your doctor if you have any questions or concerns.

Brochure: Is your Allergic Rhinitis (Hay Fever) difficult to manage? Have you heard of immunotherapy?

Download brochure here: pdfIs your Allergic Rhinitis (Hay Fever) difficult to manage? Have you heard of immunotherapy?854.86 KB

Is your Allergic Rhinitis Hay Fever difficult to manage?

Webinar: Allergic Rhinitis and Allergen Immunotherapy

In this webinar Professor Connie Katelaris shares information on allergic rhinitis and allergen immunotherapy.

View the webinar in full or go directly to information concerning allergic rhinitis or allergen immunotherapy by selecting the titles below. 

Allergic Rhinitis and Allergen Immunotherapy Webinar (full)

Allergic Rhinitis

Allergen Immunotherapy

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
250K Teens/youngs adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • NSW Food Authority
  • Novartis
  • Pfizer
  • Stallergenes Greer

Gold


  • abbvie
  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • Australian Camps Association
  • Bayer
  • Bulla
  • Sanctuary Early Learning
  • Sweet William

© 2022 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 


ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.